Goldman Sachs’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-91,527
| Closed | -$520K | – | 6683 |
|
|
2025
Q4 | $520K | Sell |
91,527
-27,056
| -23% | -$153K | ﹤0.01% | 5571 |
|
|
2025
Q3 | $726K | Buy |
118,583
+12,174
| +11% | +$63.1K | ﹤0.01% | 5272 |
|
|
2025
Q2 | $341K | Sell |
106,409
-2,201
| -2% | -$8.48K | ﹤0.01% | 5373 |
|
|
2025
Q1 | $440K | Sell |
108,610
-12,217
| -10% | -$85.8K | ﹤0.01% | 5262 |
|
|
2024
Q4 | $1.28M | Buy |
120,827
+2,007
| +2% | +$35.8K | ﹤0.01% | 4640 |
|
|
2024
Q3 | $2.93M | Sell |
118,820
-8,682
| -7% | -$230K | ﹤0.01% | 3812 |
|
|
2024
Q2 | $3.6M | Buy |
127,502
+3,293
| +3% | +$107K | ﹤0.01% | 3459 |
|
|
2024
Q1 | $5.06M | Buy |
124,209
+8,258
| +7% | +$194K | ﹤0.01% | 3079 |
|
|
2023
Q4 | $1.91M | Buy |
115,951
+46,904
| +68% | +$818K | ﹤0.01% | 3958 |
|
|
2023
Q3 | $2.62M | Sell |
69,047
-3,048
| -4% | -$144K | ﹤0.01% | 3550 |
|
|
2023
Q2 | $3.97M | Buy |
72,095
+3,141
| +5% | +$144K | ﹤0.01% | 3307 |
|
|
2023
Q1 | $2.97M | Sell |
68,954
-11,246
| -14% | -$544K | ﹤0.01% | 3535 |
|
|
2022
Q4 | $3.15M | Sell |
80,200
-1,358
| -2% | -$71.3K | ﹤0.01% | 3570 |
|
|
2022
Q3 | $4.33M | Buy |
81,558
+60,196
| +282% | +$3.77M | ﹤0.01% | 3251 |
|
|
2022
Q2 | $1.4M | Buy |
21,362
+845
| +4% | +$55.2K | ﹤0.01% | 4354 |
|
|
2022
Q1 | $1.51M | Buy |
20,517
+13,418
| +189% | +$777K | ﹤0.01% | 4481 |
|
|
2021
Q4 | $503K | Sell |
7,099
-27,804
| -80% | -$4.85M | ﹤0.01% | 5378 |
|
|
2021
Q3 | $8.75M | Sell |
34,903
-2,959
| -8% | -$709K | ﹤0.01% | 2851 |
|
|
2021
Q2 | $10.2M | Sell |
37,862
-14,574
| -28% | -$4.36M | ﹤0.01% | 2673 |
|
|
2021
Q1 | $14.9M | Buy |
52,436
+35,837
| +216% | +$11.5M | ﹤0.01% | 2191 |
|
|
2020
Q4 | $4.71M | Buy |
16,599
+15,847
| +2,107% | +$5.09M | ﹤0.01% | 3046 |
|
|
2020
Q3 | $232K | Sell |
752
-4,508
| -86% | -$1.08M | ﹤0.01% | 4855 |
|
|
2020
Q2 | $1.1M | Buy |
+5,260
| New | +$1.17M | ﹤0.01% | 3877 |
|
Other funds holding GBIO
Goldman Sachs's GBIO Position: Q1 2026 in Review
Goldman Sachs sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 91,527 shares — an estimated $520K sold.
Goldman Sachs first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $14.9M in Q1 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Goldman Sachs reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Goldman Sachs sold 91,527 Generation Bio shares in Q1 2026, an estimated $520K.
- Goldman Sachs first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
- Goldman Sachs's Generation Bio position peaked at $14.9M in Q1 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.